Latest Funding News

3D Energi has confirmed two significant gas discoveries in the Otway Basin but now confronts a funding shortfall that has led to a trading suspension on the ASX.

Aureka Limited reports breakthrough high-grade gold assays at its Irvine and St Arnaud projects, alongside a successful $3.6 million capital raise to accelerate exploration in Victoria’s historic goldfields.

Charger Metals NL advances its lithium and gold exploration with promising resource growth at Lake Johnston and new discoveries at Bynoe, supported by soaring commodity prices.

Charger Metals NL has raised $1.35 million through a well-supported placement to fund extensive drilling at its Lake Johnston Lithium and Gold Project, targeting promising new discoveries and resource expansion.

AnteoTech has raised A$3.5 million through a discounted share placement to accelerate commercialisation of its advanced battery and life sciences technologies globally. The capital injection supports strategic partnerships and sales expansion in key markets including the US and India.

AML3D Limited has reported a remarkable 360% increase in customer receipts for the December 2025 quarter, driven by strong demand from the US defence sector and a robust order book of A$16.5 million for FY26. The company is accelerating its US scale-up strategy while expanding into UK and European defence markets.

HeraMED Limited has completed a $3.2 million placement to fund its global rollout of digital maternity care solutions, backed by new and existing institutional investors.

Australian Dairy Nutritionals Limited (AHF) is raising approximately $3.47 million through a pro-rata entitlement offer to accelerate its growth plans in China and enhance processing efficiency.

Regal Partners Limited reported a robust 16% growth in Funds Under Management (FUM) to $20.9 billion by the end of 2025, driven by strong client inflows and solid investment returns. The company’s total FUM and commitments climbed 21% to $22 billion, reflecting broad-based demand across multiple asset strategies.

Highfield Resources has secured a A$10 million investment from existing strategic shareholders, extending its financial runway through early 2027 while awaiting a critical Spanish Supreme Court ruling on its Goyo mining permit appeal.

Neurizon Therapeutics has successfully raised $5.88 million through a well-supported entitlement offer, reinforcing investor confidence as it prepares to advance its lead drug candidate NUZ-001 in the HEALEY ALS Platform Trial.

Elsight Limited capped 2025 with record quarterly revenue and a substantial US$21.2 million contract, signalling robust growth and expanding global defence engagements heading into 2026.